192 related articles for article (PubMed ID: 19581936)
1. Overexpression of Csk-binding protein contributes to renal cell carcinogenesis.
Feng X; Lu X; Man X; Zhou W; Jiang LQ; Knyazev P; Lei L; Huang Q; Ullrich A; Zhang Z; Chen Z
Oncogene; 2009 Sep; 28(37):3320-31. PubMed ID: 19581936
[TBL] [Abstract][Full Text] [Related]
2. The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.
Kanou T; Oneyama C; Kawahara K; Okimura A; Ohta M; Ikeda N; Shintani Y; Okumura M; Okada M
Mol Cancer Res; 2011 Jan; 9(1):103-14. PubMed ID: 21156787
[TBL] [Abstract][Full Text] [Related]
3. Transmembrane phosphoprotein Cbp senses cell adhesion signaling mediated by Src family kinase in lipid rafts.
Shima T; Nada S; Okada M
Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14897-902. PubMed ID: 14645715
[TBL] [Abstract][Full Text] [Related]
4. Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation.
Jiang LQ; Feng X; Zhou W; Knyazev PG; Ullrich A; Chen Z
Oncogene; 2006 Sep; 25(40):5495-506. PubMed ID: 16636672
[TBL] [Abstract][Full Text] [Related]
5. Sperm-associated antigen 9 is associated with tumor growth, migration, and invasion in renal cell carcinoma.
Garg M; Kanojia D; Khosla A; Dudha N; Sati S; Chaurasiya D; Jagadish N; Seth A; Kumar R; Gupta S; Gupta A; Lohiya NK; Suri A
Cancer Res; 2008 Oct; 68(20):8240-8. PubMed ID: 18922895
[TBL] [Abstract][Full Text] [Related]
6. The lipid raft-anchored adaptor protein Cbp controls the oncogenic potential of c-Src.
Oneyama C; Hikita T; Enya K; Dobenecker MW; Saito K; Nada S; Tarakhovsky A; Okada M
Mol Cell; 2008 May; 30(4):426-36. PubMed ID: 18498747
[TBL] [Abstract][Full Text] [Related]
7. The ups and downs of SRC regulation: tumor suppression by Cbp.
Resh MD
Cancer Cell; 2008 Jun; 13(6):469-71. PubMed ID: 18538730
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Csk-binding protein decreases growth, invasion, and migration of esophageal carcinoma cells by controlling Src activation.
Zhou D; Dong P; Li YM; Guo FC; Zhang AP; Song RZ; Zhang YM; Li ZY; Yuan D; Yang C
World J Gastroenterol; 2015 Feb; 21(6):1814-20. PubMed ID: 25684946
[TBL] [Abstract][Full Text] [Related]
9. A displaced PAG enhances proximal signaling and SDF-1-induced T cell migration.
Posevitz-Fejfár A; Smída M; Kliche S; Hartig R; Schraven B; Lindquist JA
Eur J Immunol; 2008 Jan; 38(1):250-9. PubMed ID: 18085663
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling.
Kojima T; Shimazui T; Hinotsu S; Joraku A; Oikawa T; Kawai K; Horie R; Suzuki H; Nagashima R; Yoshikawa K; Michiue T; Asashima M; Akaza H; Uchida K
Oncogene; 2009 Jan; 28(2):297-305. PubMed ID: 18931698
[TBL] [Abstract][Full Text] [Related]
11. AKAPs competing peptide HT31 disrupts the inhibitory effect of PKA on RhoA activity.
Wang Y; Chen Y; Chen M; Xu W
Oncol Rep; 2006 Oct; 16(4):755-61. PubMed ID: 16969490
[TBL] [Abstract][Full Text] [Related]
12. Functional significance of Wnt inhibitory factor-1 gene in kidney cancer.
Kawakami K; Hirata H; Yamamura S; Kikuno N; Saini S; Majid S; Tanaka Y; Kawamoto K; Enokida H; Nakagawa M; Dahiya R
Cancer Res; 2009 Nov; 69(22):8603-10. PubMed ID: 19887605
[TBL] [Abstract][Full Text] [Related]
13. Cbp recruitment of Csk into lipid rafts is critical to c-Src kinase activity and bone resorption in osteoclasts.
Matsubara T; Ikeda F; Hata K; Nakanishi M; Okada M; Yasuda H; Nishimura R; Yoneda T
J Bone Miner Res; 2010 May; 25(5):1068-76. PubMed ID: 19874196
[TBL] [Abstract][Full Text] [Related]
14. Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor.
Shoji S; Tang XY; Umemura S; Itoh J; Takekoshi S; Shima M; Usui Y; Nagata Y; Uchida T; Osamura RY; Terachi T
Eur Urol; 2009 Feb; 55(2):441-9. PubMed ID: 18395325
[TBL] [Abstract][Full Text] [Related]
15. Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response.
Balamurugan K; Luu VD; Kaufmann MR; Hofmann VS; Boysen G; Barth S; Bordoli MR; Stiehl DP; Moch H; Schraml P; Wenger RH; Camenisch G
Oncogene; 2009 Sep; 28(37):3274-85. PubMed ID: 19581925
[TBL] [Abstract][Full Text] [Related]
16. Tpl2 kinase impacts tumor growth and metastasis of clear cell renal cell carcinoma.
Lee HW; Joo KM; Lim JE; Cho HJ; Cho HJ; Park MC; Seol HJ; Seo SI; Lee JI; Kim S; Jeong BC; Nam DH
Mol Cancer Res; 2013 Nov; 11(11):1375-86. PubMed ID: 23982215
[TBL] [Abstract][Full Text] [Related]
17. Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases.
Kawabuchi M; Satomi Y; Takao T; Shimonishi Y; Nada S; Nagai K; Tarakhovsky A; Okada M
Nature; 2000 Apr; 404(6781):999-1003. PubMed ID: 10801129
[TBL] [Abstract][Full Text] [Related]
18. Down-regulated expression of RhoA in human conventional renal cell carcinoma.
Pu YS; Wang CW; Liu GY; Kuo YZ; Huang CY; Kang WY; Shun CT; Lin CC; Wu WJ; Hour TC
Anticancer Res; 2008; 28(4B):2039-43. PubMed ID: 18751372
[TBL] [Abstract][Full Text] [Related]
19. Cbp deficiency alters Csk localization in lipid rafts but does not affect T-cell development.
Xu S; Huo J; Tan JE; Lam KP
Mol Cell Biol; 2005 Oct; 25(19):8486-95. PubMed ID: 16166631
[TBL] [Abstract][Full Text] [Related]
20. Interactions between the Fyn SH3-domain and adaptor protein Cbp/PAG derived ligands, effects on kinase activity and affinity.
Solheim SA; Petsalaki E; Stokka AJ; Russell RB; Taskén K; Berge T
FEBS J; 2008 Oct; 275(19):4863-74. PubMed ID: 18721137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
